156 related articles for article (PubMed ID: 33836418)
1. DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications.
Sadoughi F; Maleki Dana P; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jun; 102():103105. PubMed ID: 33836418
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma.
Alemi F; Malakoti F; Vaghari-Tabari M; Soleimanpour J; Shabestani N; Sadigh AR; Khelghati N; Asemi Z; Ahmadi Y; Yousefi B
J Cell Physiol; 2022 May; 237(5):2374-2386. PubMed ID: 35383920
[TBL] [Abstract][Full Text] [Related]
3. 2-Hydroxy-3-methylanthraquinone inhibits homologous recombination repair in osteosarcoma through the MYC-CHK1-RAD51 axis.
Jing D; Chen X; Zhang Z; Chen F; Huang F; Zhang Z; Wu W; Shao Z; Pu F
Mol Med; 2023 Jan; 29(1):15. PubMed ID: 36717782
[TBL] [Abstract][Full Text] [Related]
4. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B
DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757
[TBL] [Abstract][Full Text] [Related]
5. DNA damage response and repair in pancreatic cancer development and therapy.
Rahnamay Farnood P; Danesh Pazhooh R; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jul; 103():103116. PubMed ID: 33882393
[TBL] [Abstract][Full Text] [Related]
6. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F
J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells in osteosarcoma.
Brown HK; Tellez-Gabriel M; Heymann D
Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
[TBL] [Abstract][Full Text] [Related]
8. Germline mutations in BAP1 impair its function in DNA double-strand break repair.
Ismail IH; Davidson R; Gagné JP; Xu ZZ; Poirier GG; Hendzel MJ
Cancer Res; 2014 Aug; 74(16):4282-94. PubMed ID: 24894717
[TBL] [Abstract][Full Text] [Related]
9. HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.
Wang H; Sun W; Sun M; Fu Z; Zhou C; Wang C; Zuo D; Zhou Z; Wang G; Zhang T; Xu J; Chen J; Wang Z; Yin F; Duan Z; Hornicek FJ; Cai Z; Hua Y
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1839-1849. PubMed ID: 29524631
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of TRDMT1 impairs exogenous RNA-based response and promotes retrotransposon activity during long-term culture of osteosarcoma cells.
Betlej G; Lewińska A; Adamczyk-Grochala J; Błoniarz D; Rzeszutek I; Wnuk M
Toxicol In Vitro; 2022 Apr; 80():105323. PubMed ID: 35104602
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
12. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
13. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma.
Fan GT; Ling ZH; He ZW; Wu SJ; Zhou GX
Biochem Biophys Res Commun; 2021 May; 554():214-221. PubMed ID: 33813077
[TBL] [Abstract][Full Text] [Related]
14. IMPDH2 mediate radioresistance and chemoresistance in osteosarcoma cells.
Li HX; Meng QP; Liu W; Li YG; Zhang HM; Bao FC; Song LL; Li HJ
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3038-44. PubMed ID: 25392102
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
16. 7-hydroxy-staurosporine, UCN-01, induces DNA damage response, and autophagy in human osteosarcoma U2-OS cells.
Lien WC; Chen TY; Sheu SY; Lin TC; Kang FC; Yu CH; Kuan TS; Huang BM; Wang CY
J Cell Biochem; 2018 Jun; 119(6):4729-4741. PubMed ID: 29280173
[TBL] [Abstract][Full Text] [Related]
17. miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis.
Song YD; Li DD; Guan Y; Wang YL; Zheng J
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):75-79. PubMed ID: 28980925
[TBL] [Abstract][Full Text] [Related]
18. CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells.
Jiang Z; Jiang J; Zhao B; Yang H; Wang Y; Guo S; Deng Y; Lu D; Ma T; Wang H; Wang J
Oncol Rep; 2018 Feb; 39(2):643-650. PubMed ID: 29207139
[TBL] [Abstract][Full Text] [Related]
19. New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma.
Lu KH; Lu EW; Lin CW; Yang JS; Yang SF
Pharmacol Ther; 2020 Oct; 214():107611. PubMed ID: 32565177
[TBL] [Abstract][Full Text] [Related]
20. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
